Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HK-660S by Curome Bioscience for MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes): Likelihood of Approval
HK-660S is under clinical development by Curome Bioscience and currently in Phase II for MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis...